Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC)
Closed
Phase 2
This trial is looking at a drug called afatinib before surgery for people with early stage non small cell lung cancer.
Recruitment start: 23 July 2014
Recruitment end: 30 September 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Clive Mulatero
Boehringer Ingelheim
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Leeds
Last reviewed: 26 Oct 2016
CRUK internal database number: 11075